India to Canada: Celecoxib Export Trade Route

The India to Canada Celecoxib corridor is one of India's established pharmaceutical export routes, with 295 shipments documented worth a combined $7.1M USD. The route is dominated by APOTEX RESEARCH PRIVATE LIMITED, which alone accounts for roughly 36% of all export value, reflecting the consolidated nature of India's celecoxib manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $23.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (66%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 19 days port-to-port. The route has recorded an annual growth rate of 28.4%, placing it at rank #6 among India's top celecoxib export destinations globally.

On the import side, key buyers of Indian celecoxib in Canada include APOTEX INC,, APOTEX INC, MARCAN PHARMACEUTICALS INC. and 26 others. APOTEX INC, is the single largest importer with 31 shipments valued at $1.3M USD.

India's celecoxib exports to Canada are driven primarily by a handful of large-scale manufacturers. APOTEX RESEARCH PRIVATE LIMITED with 60 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Canada benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — APOTEX RESEARCH PRIVATE LIMITED, EMCURE PHARMACEUTICALS LIMITED, EMCURE PHARMACEUTICALS LIMITED — together account for 68% of total trade value on this route. The average shipment value of $23.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as apo-celecoxib cap 200mg 100 btl 53810/77 and apo-celecoxib cap 200mg 100 btl 53810/77, suggesting that buyers in Canada tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, APOTEX INC, is the largest importer with 31 shipments worth $1.3M USD — representing 18% of all celecoxib imports from India on this route. A total of 29 buyers are active on this corridor.